公司概覽
業務類別 Medical Devices
業務概覽 One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
公司地址 Parkmore Business Park West, Building Two, Galway, IRL
電話號碼 +353 14381700
傳真號碼 --
公司網頁 https://www.medtronic.com
員工數量 95000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 美元 1.40M 17/08/2026
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio -- 18/06/2026
Ms. Michelle Quinn Executive Vice President, General Counsel and Secretary 美元 600.00K 17/08/2026
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio , Americas, and Global Commercial Operations 美元 819.62K 17/08/2026
Mr. Matthew R. Walter Senior Vice President, Human Resources, IT, and Global Communications and Corporate Marketing -- 18/06/2026
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President 美元 849.65K 17/08/2026
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer -- 18/06/2026
Dr. Kweli Thompson Executive Vice President and President, Neuroscience Portfolio -- 18/05/2026
 
董事會成員
董事會 職務 更新日期
Mr. Craig Arnold Lead Independent Director 17/08/2026
Mr. Kendall J. Powell Independent Director 17/08/2026
Ms. Lidia L. Fonseca Independent Director 17/08/2026
Mr. Randall J. Hogan, III Independent Director 17/08/2026
Mr. William R. Jellison Independent Director 17/08/2026
Mr. Scott C. Donnelly Independent Director 17/08/2026
Mr. Kevin E. Lofton Independent Director 17/08/2026
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 17/08/2026
Mr. John P. Groetelaars Independent Director 17/08/2026
Dr. Elizabeth G. Nabel, M.D. Independent Director 17/08/2026
Mr. Gregory P. Lewis Independent Director 17/08/2026
Dr. Joon S. Lee, M.D. Independent Director 17/08/2026
 
所屬ETF (更新日期: 19/09/2026 03:28)
代號 名稱 佔比% ▼ 持有日期
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.0001%30/07/2026
CDPIColumbia High Dividend Prm Inc ETF0.00005%31/07/2026
JDIVJPMorgan Dividend Leaders ETF0.00005%31/07/2026
SPYHNEOS S&P 500 Hedged Equity Income ETF0.00005%31/07/2026
BALQiShares Nasdaq Premium Income Active ETF0.00004%31/07/2026
JUDOJanus Henderson U.S. Eq Enhanced Inc ETF0.00004%31/07/2026
YUNGCorgi Longevity Consumer ETF0.00004%31/07/2026
SIOOVistaShares Target 15TM S&P 100 Dis ETF0.00004%31/07/2026
AVTMAvantis Total Equity Markets ETF0.00004%31/07/2026
STXGStrive 1000 Growth ETF0.00004%31/07/2026
GLOFiShares Global Equity Factor ETF0.00003%31/07/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.00003%31/07/2026
JDOCJPMorgan Healthcare Leaders ETF0.00003%31/07/2026
NTSDWisdomTree Efficient U.S. Pls Intl Eq Fd0.00003%31/07/2026
SNPDXtrackers S&P Div Arstcrts Scrn ETF0.00003%30/07/2026
CHRIGlobal X S&P 500 Christian Values ETF0.00002%31/07/2026
DVVYInvesco Diversified Dividend Opports ETF0.00002%31/07/2026
AELVHarbor AlphaEdge Large Cap Value ETF0.00002%29/08/2026
JPFPJPMorgan Managed Futures Plus ETF0.00002%31/07/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00002%31/07/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17   18    19    20    21    22    23    24  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.